{
    "doi": "https://doi.org/10.1182/blood.V130.Suppl_1.1559.1559",
    "article_title": "Geltamo-IPI Distinctly Identifies a Very High Risk Group in Difuse Large B-Cell Lymphoma (DLBCL) of Non B-Germinal-Center Origin Treated with Chemo-Immunotherapy ",
    "article_date": "December 7, 2017",
    "session_type": "627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)\u2014Results from Retrospective/Observational Studies: Poster I",
    "abstract_text": "Backgound . GELTAMO-IPI has shown to have better prognostic effect than NCCN-IPI for DLBCL treated with immunochemotherapy (BJH;2017;176;918) with the additional advantages to identify a real high risk group and not being influenced by the primary extranodal presentation or the use of treatment more intense than R-CHOP. The variables in GELTAMO-IPI and its statistical weight are: age (<65 years: 0 points; \u226565-79:1 pt.; \u226580 2 pt.), PS (0-1: 0 p.; 2: 1pt. \u22652: 2 pt.), >LDH, > \u03b2 2 mcg and stage IV , one point each. The combination of these factors separate four risk groups, Low risk ( LR , 0 points), Low-Intermediate risk ( LIR , 1-3 points), High-Intermediate risk ( HIR , 4 points and High Risk ( HR \u22655 points), with 5-year overall (5y-OS) survival of 93%, 79%, 66% and 39%, respectively. Aims. Present study explores the prognostic effect of GELTAMO-IPI in the histological subgroups depending of the cell of origin: B Germinal Center ( BGC ) or non B Germinal Center (N on-BGC). Methods. the original series for the development of GELTAMO-IPI comprised 1848 patients. The BGC/non-BGC origin was calculated with the Hans algorithm by the Immunohistochemical expression of 3 markers (CD10, BCL6 and MUM-1) being available in 1097 patients. The statistical study consisted in the development of a Cox model which includes the three variables: GELTAMO-IPI groups (LR, LIR, HIR, HR), cell of origin (BGC/non-BGC) and its product in order to evaluate the presence of interaction between these variables. Kaplan-Meier and Log-rank were used for survival curves and comparison. Results. The cell of origin was retrieved in 1097 patients: 380 BGC, 459 non-BGC and 258 non-evaluable. The series includes: LR 72 p. (9.2%), LIR 464 p. (59.5%), HIR 127 p. (16.3%) and HR 117 p. (15%) with 5y-OS of 98%, 79%, 67% and 41%, respectively. The Cox model showed interaction between the risk groups and the GBC/non-GBC origin (p=0.005), indicating that GELTAMO-IPI has a different effect in each group. In the BGC-DLBCL group with LR (34 p.), LIR (221 p.), HIR (53 p.) and HR (45 p.) the 5y-OS differences between LR and LIR are maintained (100%, 75%, respectively), but not between HIR and HR (53% and 51%); Nevertheless, GELTAMO-IPI stratified 3 distinct risk groups (LR, LIR and HIR+HR), although it is not able to identify a real high risk group of patients (Figure 1, left panel). In the Non-BGC-DLBCL the differences among the LR, LIR and HIR groups (38, 243, and 74 patients with 5y-OS of 97%, 82% and 77%) have lower significance than in the original study (p=0.01 and p=0,26, respectively), but a distinct HR group of 72 patients with a 5yOS of 35% is clearly identified (p<0.001) (Figure 1, right panel). Conclusions . GELTAMO-IPI separates three risk groups in BGC-DLBCL, but fails to identify a genuine HR group, whereas GELTAMO-IPI in the non-BGC-DLBCL positively identifies a real high risk group. This different outcome in the GC-DLBCL and non-GC-DLBCL using simple clinical factors, as included in GELTAMO-IPI, represents an interesting practical prognostic tool in the clinical practice. Figure 1 View large Download slide Figure 1 View large Download slide Close modal Disclosures Diaz-Lopez: TFS: Employment. Mart\u00edn: Gilead: Consultancy; Janssen: Honoraria; Servier: Consultancy, Honoraria; Celgene: Consultancy, Honoraria; Roche: Consultancy, Honoraria. Sancho: Roche: Honoraria; Gilead: Honoraria; Celgene: Honoraria; Janssen: Honoraria; Laboratorios Servier: Consultancy; Kern Pharma: Honoraria; Mundipharma: Honoraria. Salar: Servier: Speakers Bureau; Janssen: Speakers Bureau; Roche: Speakers Bureau. Gutierrez: JANSSEN: Consultancy, Research Funding, Speakers Bureau; ROCHE: Research Funding, Speakers Bureau; SERVIER: Speakers Bureau; GILEAD: Honoraria; TAKEDA: Speakers Bureau; PFIZER: Consultancy. Lopez-Guillermo: Janssen: Consultancy; Gilead: Consultancy; Celgene: Consultancy; Roche: Consultancy, Other: Research grant; Novartis: Consultancy.",
    "topics": [
        "b-lymphocytes",
        "chemotherapy regimen",
        "diffuse large b-cell lymphoma",
        "immunotherapy",
        "lymphoma",
        "extranodal disease",
        "neprilysin",
        "r-chop",
        "survival curve",
        "germinal center of lymph node"
    ],
    "author_names": [
        "Carlos Montalban, MD PhD",
        "Antonio Diaz-Lopez",
        "Alejandro Mart\u00edn, MD PhD",
        "Monica Baile, MD",
        "Jose M. Sanchez",
        "Juan-Manuel Sancho, MD PhD",
        "Olga Garc\u00eda",
        "Silvana Novelli",
        "Ana Monter Rovira",
        "Antonio Salar, MD PhD",
        "Mariana Bastos, MD",
        "Antonio Gutierrez, MD PhD",
        "Raul Cordoba, MDPhD",
        "Teresa Arquero",
        "Sonia Gonz\u00e1lez de Villambrosia",
        "Gilberto Barranco",
        "Raquel de O\u00f1a",
        "Azueg Hong",
        "Maria Casanova",
        "Armando Lopez-Guillermo",
        "Maria J. Rodriguez-Salazar",
        "Juan F. Dominguez",
        "Ruben Fernandez",
        "Jose Antonio Queizan",
        "Jose Rodriguez",
        "Victor Abraira",
        "Juan F. Garcia"
    ],
    "author_dict_list": [
        {
            "author_name": "Carlos Montalban, MD PhD",
            "author_affiliations": [
                "Department of Hematology, MD Anderson Cancer Center, Madrid, Spain "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Antonio Diaz-Lopez",
            "author_affiliations": [
                "Translational Research, MD Anderson Cancer Center, Madrid, Spain "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alejandro Mart\u00edn, MD PhD",
            "author_affiliations": [
                "Department of Hematology, Hospital Universitario de Salamanca / IBSAL, Salamanca, ESP "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Monica Baile, MD",
            "author_affiliations": [
                "Hospital Clinico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jose M. Sanchez",
            "author_affiliations": [
                "Hospital Universitario 12 de Octubre, Madrid, Spain "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Juan-Manuel Sancho, MD PhD",
            "author_affiliations": [
                "Hematology Department, ICO-IJC Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Olga Garc\u00eda",
            "author_affiliations": [
                "Hospital Universitari Germans Trias i Pujol, Barcelona, Spain "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Silvana Novelli",
            "author_affiliations": [
                "Department of Hematology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ana Monter Rovira",
            "author_affiliations": [
                "Department of Hematology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonio Salar, MD PhD",
            "author_affiliations": [
                "Department of Haematology, Hospital del Mar, Barcelona, Spain "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mariana Bastos, MD",
            "author_affiliations": [
                "Department of Hematology, Gregorio Mara\u00f1\u00f3n General University Hospital (HGUGM), Madrid, Spain "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonio Gutierrez, MD PhD",
            "author_affiliations": [
                "Department of Hematology, Hospital Universitari Son Espases / IdISBa, Palma, Spain "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Raul Cordoba, MDPhD",
            "author_affiliations": [
                "Department of Hematology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Teresa Arquero",
            "author_affiliations": [
                "Department of Hematology, Fundaci\u00f3n Jimenez D\u00edaz, Madrid, Spain "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sonia Gonz\u00e1lez de Villambrosia",
            "author_affiliations": [
                "Department of Hematology, Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Spain "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gilberto Barranco",
            "author_affiliations": [
                "Translational Research, MD Anderson Cancer Center, Madrid, Spain "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Raquel de O\u00f1a",
            "author_affiliations": [
                "Department of Hematology, MD Anderson Cancer Center, Madrid, Spain "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Azueg Hong",
            "author_affiliations": [
                "Department of Hematology, H. de Lanzarote, Lanzarote, Spain "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Casanova",
            "author_affiliations": [
                "Department of Hematology, Hospital Costa del Sol Marbella, Marbella, Spain "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Armando Lopez-Guillermo",
            "author_affiliations": [
                "Hematology, Hospital Clinic, Barcelona, Spain "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria J. Rodriguez-Salazar",
            "author_affiliations": [
                "Department of Hematology, Hospital Universitario de Canarias, Santa Cruz Tenerife, Spain "
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Juan F. Dominguez",
            "author_affiliations": [
                "Department of Hematology, Hospital Virgen del Roc\u00edo, Seville, Spain "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ruben Fernandez",
            "author_affiliations": [
                "Department of Hematology, Hospital de Cabue\u00f1es, Gijon, Spain "
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jose Antonio Queizan",
            "author_affiliations": [
                "Department of Hematology, Hospital General de Segovia, Segovia, Spain "
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jose Rodriguez",
            "author_affiliations": [
                "Department of Hematology, MD Anderson Cancer Center, Madrid, Spain "
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Victor Abraira",
            "author_affiliations": [
                "Fundaci\u00f3n del IRYCIS. Hospital Ram\u00f3n y Cajal, Madrid, Spain "
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Juan F. Garcia",
            "author_affiliations": [
                "Translational Research and Pathology, MD Anderson Cancer Center, Madrid, Spain"
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-10T06:45:20",
    "is_scraped": "1"
}